The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques: A Role for Apoptosis in Plaque Thrombogenicity
Abstract
Background —The specific role of apoptosis in human atherosclerosis remains unknown. During apoptotic cell death, phosphatidylserine exposure on the cell surface confers a high tissue-factor (TF)–dependent procoagulant activity. Methods and Results —In this study, we examined the role of apoptotic cell death in the promotion of plaque thrombogenicity. TF expression and its relation to apoptosis was analyzed in 16 human atherosclerotic plaques by the use of immunohistochemical techniques. The presence of shed membrane apoptotic microparticles was analyzed in extracts from 6 human atherosclerotic plaques and 3 underlying arterial walls. The microparticles were captured by annexin V and their amounts estimated with respect to their phospholipid content by use of a prothrombinase assay. The prothrombogenic potential of the microparticles was further assessed by the measurement of total and microparticle-dependent TF activity in the extracts. The cell origin of the microparticles was determined after capture by specific antibodies. We were able to detect marked TF expression in the plaques in close proximity to apoptotic cells and debris, suggesting a potential interaction between TF and the apoptotic cell surfaces. High levels of shed membrane apoptotic microparticles were detected in extracts from atherosclerotic plaques but not in the underlying arterial walls (29.5±3.7 nmol/L phosphatidylserine equivalent versus 1.3±0.4 nmol/L, respectively, P <0.02). The microparticles were mainly of monocytic and lymphocytic origin and retained 97±2% of total TF activity, indicating a direct causal relationship between shed membrane microparticles and procoagulant activity of plaque extracts. Conclusions —These results indicate that shed membrane microparticles with procoagulant potential are produced in human atherosclerotic plaques. Apoptosis could be a critical determinant of plaque thrombogenicity after plaque rupture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., & Green, D. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1545 · Cited by 2,824
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly
Burke, A. P., Farb, A., Malcom, G. T., Liang, Y.-H., Smialek, J., & Virmani, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705013361802 · Cited by 1,745
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.
Wilcox, J. N., Smith, K. M., Schwartz, S. M., & Gordon, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2839 · Cited by 1,214
Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995
Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.8.2013 · Cited by 915
Bennett, M. R., Evan, G. I., & Schwartz, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117917 · Cited by 703
Apoptosis in Human Atherosclerosis and Restenosis
Isner, J. M., Kearney, M., Bortman, S., & Passeri, J. (1995) · Circulation · doi:10.1161/01.cir.91.11.2703 · Cited by 672
Geng, Y., & Libby, P. (1995) · Europe PMC (PubMed Central) · Cited by 640
Apoptotic Vascular Endothelial Cells Become Procoagulant
Bombeli, T., Karsan, A., Tait, J. F., & Harlan, J. M. (1997) · Blood · doi:10.1182/blood.v89.7.2429 · Cited by 622
Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques
Toschi, V., Gallo, R., Lettino, M., Fallon, J. T., Gertz, S. D., Ferna´ndez-Ortiz, A., Chesebro, J. H., Badimon, L., Nemerson, Y., Fuster, V., et al. (1997) · Circulation · doi:10.1161/01.cir.95.3.594 · Cited by 603
Cited by
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Self-citationExtracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Macrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J.-M., & Tedgui, A. (2000) · Circulation · doi:10.1161/01.cir.101.8.841 · Cited by 883
Self-citationFocus on Extracellular Vesicles: Introducing the Next Small Big Thing
Kalra, H., Drummen, G., & Mathivanan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020170 · Cited by 862
Microparticles in Hemostasis and Thrombosis
Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835
Protective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
Self-citationAtherothrombosis and High-Risk Plaque
Fuster, V., Moreno, P. R., Fayad, Z. A., Corti, R., & Badimon, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.074 · Cited by 738
Arterial thrombosis—insidious, unpredictable and deadly
Jackson, S. P. (2011) · Nature Medicine · doi:10.1038/nm.2515 · Cited by 685
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Grover, S. P., & Mackman, N. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309846 · Cited by 667
Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development
Mackman, N. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000130465.23430.74 · Cited by 658
Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin
Kobayashi, H., Ouchi, N., Kihara, S., Walsh, K., Kumada, M., Abe, Y., Funahashi, T., & Matsuzawa, Y. (2004) · Circulation Research · doi:10.1161/01.res.0000119921.86460.37 · Cited by 658
Tabas, I. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000184783.04864.9f · Cited by 641
The Many Faces of Endothelial Microparticles
Dignat-George, F., & Boulanger, C. M. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.218123 · Cited by 635
Microparticles in cardiovascular diseases
VANWIJK, M., VANBAVEL, E., STURK, A., & NIEUWLAND, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00367-5 · Cited by 610
Mack, M., Kleinschmidt, A., Brühl, H., Klier, C., Nelson, P. J., Cihak, J., Plachý, J., Stangassinger, M., Erfle, V., & Schlöndorff, D. (2000) · Nature Medicine · doi:10.1038/77498 · Cited by 605
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
Nieuwland, R., Berckmans, R. J., McGregor, S., Böing, A. N., Th. M. Romijn, F. P. H., Westendorp, R. G. J., Hack, C. E., & Sturk, A. (2000) · Blood · doi:10.1182/blood.v95.3.930.003k46_930_935 · Cited by 574
Mechanisms of plaque vulnerability and rupture
Shah, P. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02834-6 · Cited by 541
Extracellular vesicles in coronary artery disease
Boulanger, C. M., Loyer, X., Rautou, P.-E., & Amabile, N. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.7 · Cited by 514
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
Schrijvers, D. M., De Meyer, G. R. Y., Kockx, M. M., Herman, A. G., & Martinet, W. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000166517.18801.a7 · Cited by 509
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Zen, K., & Zhang, C. (2012) · Medicinal Research Reviews · doi:10.1002/med.20215 · Cited by 502
Effects of Severe Hypertension on Endothelial and Platelet Microparticles
Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., Aime, G., & Ahn, Y. S. (2003) · Hypertension · doi:10.1161/01.hyp.0000049760.15764.2d · Cited by 499
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein
Bogdanov, V. Y., Balasubramanian, V., Hathcock, J., Vele, O., Lieb, M., & Nemerson, Y. (2003) · Nature Medicine · doi:10.1038/nm841 · Cited by 467
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., & Freyssinet, J.-M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000246775.14471.26 · Cited by 460
Self-citationGermain, S. J., Sacks, G. P., Soorana, S. R., Sargent, I. L., & Redman, C. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5949 · Cited by 454
Cellular microparticles: a disseminated storage pool of bioactive vascular effectors
Morel, O., Toti, F., Hugel, B., & Freyssinet, J.-M. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000131441.10020.87 · Cited by 454
Self-citationHigh levels of circulating endothelial microparticles in patients with acute coronary syndromes
Bernal-Mizrachi, L., Jy, W., Jimenez, J. J., Pastor, J., Mauro, L. M., Horstman, L. L., de Marchena, E., & Ahn, Y. S. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00103-0 · Cited by 441
Autoimmune and Inflammatory Mechanisms in Atherosclerosis
Wick, G., Knoflach, M., & Xu, Q. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104644 · Cited by 431
Endothelial microparticles in diseases
Chironi, G. N., Boulanger, C. M., Simon, A., Dignat-George, F., Freyssinet, J.-M., & Tedgui, A. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0710-9 · Cited by 420
Self-citationCell-derived microparticles in haemostasis and vascular medicine
Burnier, L., Fontana, P., Kwak, B. R., & Angelillo-Scherrer, A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-08-0521 · Cited by 416
Measuring circulating cell‐derived microparticles
Jy, W., Horstman, L. L., Jimenez, J. J., & Ahn, Y. S. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00936.x · Cited by 411
Mallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, Y., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh1901.098735 · Cited by 407
Self-citationTricot, O., Mallat, Z., Heymes, C., Belmin, J., Lesèche, G., & Tedgui, A. (2000) · Circulation · doi:10.1161/01.cir.101.21.2450 · Cited by 404
Self-citationType 1 And Type 2 Diabetic Patients Display Different Patterns of Cellular Microparticles
Sabatier, F., Darmon, P., Hugel, B., Combes, V., Sanmarco, M., Velut, J.-G., Arnoux, D., Charpiot, P., Freyssinet, J.-M., Oliver, C., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2840 · Cited by 396
Self-citationLeroyer, A. S., Isobe, H., Lesèche, G., Castier, Y., Wassef, M., Mallat, Z., Binder, B. R., Tedgui, A., & Boulanger, C. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.053 · Cited by 389
Self-citationMicroparticles, Vascular Function, and Atherothrombosis
Rautou, P.-E., Vion, A.-C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., & Boulanger, C. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.233163 · Cited by 376
Self-citationCirculating Microparticles: A Potential Prognostic Marker for Atherosclerotic Vascular Disease
Boulanger, C. M., Amabile, N., & Tedgui, A. (2006) · Hypertension · doi:10.1161/01.hyp.0000231507.00962.b5 · Cited by 372
Self-citationLocalization of Apoptotic Macrophages at the Site of Plaque Rupture in Sudden Coronary Death
Kolodgie, F. D., Narula, J., Burke, A. P., Haider, N., Farb, A., Hui-Liang, Y., Smialek, J., & Virmani, R. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64641-x · Cited by 366
Cellular microparticles: new players in the field of vascular disease?
Diamant, M., Tushuizen, M. E., Sturk, A., & Nieuwland, R. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01355.x · Cited by 364
Koga, H., Sugiyama, S., Kugiyama, K., Watanabe, K., Fukushima, H., Tanaka, T., Sakamoto, T., Yoshimura, M., Jinnouchi, H., & Ogawa, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.047 · Cited by 362
Diamant, M., Nieuwland, R., Pablo, R. F., Sturk, A., Smit, J. W. A., & Radder, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000036596.59665.c6 · Cited by 359
Nofer, J.-R., Levkau, B., Wolinska, I., Junker, R., Fobker, M., von Eckardstein, A., Seedorf, U., & Assmann, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103782200 · Cited by 359
Role of Heat Shock Proteins in Atherosclerosis
Xu, Q. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000029720.59649.50 · Cited by 356
Mesri, M., & Altieri, D. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23111 · Cited by 349
Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes
Sinning, J.-M., Losch, J., Walenta, K., Bohm, M., Nickenig, G., & Werner, N. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq478 · Cited by 347
Apoptosis in the vasculature: mechanisms and functional importance
Mallat, Z., & Tedgui, A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703407 · Cited by 343
Self-citationPeri-procedural myocardial injury: 2005 update
Herrmann, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi455 · Cited by 325
Reinhardt, C., von Brühl, M.-L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., Hess, S., Konrad, I., Orschiedt, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32376 · Cited by 323
A current understanding of vascular calcification in CKD
Paloian, N. J., & Giachelli, C. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00163.2014 · Cited by 321
Simak, J., & Gelderman, M. P. (2006) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2005.08.001 · Cited by 314
Biró, É., Sturk-Maquelin, K. N., Vogel, G. M. T., Meuleman, D. G., Smit, M. J., Hack, C. E., Sturk, A., & Nieuwland, R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00456.x · Cited by 314
Apoptosis in atherosclerosis: beneficial or detrimental?
Kockx, M. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00235-7 · Cited by 311
Hulsmans, M., & Holvoet, P. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt161 · Cited by 308
The role of leukocytes in thrombosis
Swystun, L. L., & Liaw, P. C. (2016) · Blood · doi:10.1182/blood-2016-05-718114 · Cited by 300
Endothelial microparticles as markers of endothelial dysfunction
Horstman, L. (2004) · Frontiers in Bioscience · doi:10.2741/1270 · Cited by 300
Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences
Rauch, U., Osende, J. I., Fuster, V., Badimon, J. J., Fayad, Z., & Chesebro, J. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00014 · Cited by 297
Huber, J., Vales, A., Mitulovic, G., Blumer, M., Schmid, R., Witztum, J. L., Binder, B. R., & Leitinger, N. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.101525 · Cited by 296
A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development
Arai, S., Shelton, J. M., Chen, M., Bradley, M. N., Castrillo, A., Bookout, A. L., Mak, P. A., Edwards, P. A., Mangelsdorf, D. J., Tontonoz, P., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.02.002 · Cited by 295
The innate immune response in reperfused myocardium
Timmers, L., Pasterkamp, G., de Hoog, V. C., Arslan, F., Appelman, Y., & de Kleijn, D. P. V. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs018 · Cited by 291
The role of efferocytosis in atherosclerosis
Kojima, Y., Weissman, I. L., & Leeper, N. J. (2017) · Circulation · doi:10.1161/circulationaha.116.025684 · Cited by 289
Sabatier, F., Roux, V., Anfosso, F., Camoin, L., Sampol, J., & Dignat-George, F. (2002) · Blood · doi:10.1182/blood.v99.11.3962 · Cited by 288
Acute coronary syndromes: biology
Fuster, V., Fayad, Z. A., & Badimon, J. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90234-9 · Cited by 283
Li, Y., Ge, M., Ciani, L., Kuriakose, G., Westover, E. J., Dura, M., Covey, D. F., Freed, J. H., Maxfield, F. R., Lytton, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405195200 · Cited by 282
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall
Day, S. M., Reeve, J. L., Pedersen, B., Farris, D. M., Myers, D. D., Im, M., Wakefield, T. W., Mackman, N., & Fay, W. P. (2005) · Blood · doi:10.1182/blood-2004-06-2225 · Cited by 281
The role of plaque rupture and thrombosis in coronary artery disease
Zaman, A. G., Helft, G., Worthley, S. G., & Badimon, J. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00479-7 · Cited by 280
SCHRIJVERS, D., DEMEYER, G., HERMAN, A., & MARTINET, W. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.005 · Cited by 277
Paone, S., Baxter, A. A., Hulett, M. D., & Poon, I. K. H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2983-9 · Cited by 277
Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated Atherosclerosis in Mice
Ait-Oufella, H., Kinugawa, K., Zoll, J., Simon, T., Boddaert, J., Heeneman, S., Blanc-Brude, O., Barateau, V., Potteaux, S., Merval, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.662080 · Cited by 255
Self-citationRautou, P.-E., Leroyer, A. S., Ramkhelawon, B., Devue, C., Duflaut, D., Vion, A.-C., Nalbone, G., Castier, Y., Leseche, G., Lehoux, S., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.237420 · Cited by 255
Self-citationAit-Oufella, H., Pouresmail, V., Simon, T., Blanc-Brude, O., Kinugawa, K., Merval, R., Offenstadt, G., Lesèche, G., Cohen, P. L., Tedgui, A., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169078 · Cited by 187
Self-citationMacrophage metabolism in atherosclerosis
Bories, G. F. P., & Leitinger, N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12786 · Cited by 145
Das, D., Shruthi, N. R., Banerjee, A., Jothimani, G., Duttaroy, A. K., & Pathak, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1221438 · Cited by 90
Eating the dead to keep atherosclerosis at bay
Brophy, M. L., Dong, Y., Wu, H., Rahman, H. N. A., Song, K., & Chen, H. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00002 · Cited by 68
What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway?
Besarab, A., Frinak, S., & Yee, J. (2009) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.12.007 · Cited by 34
Guedes, V. A., Mithani, S., Williams, C., Sass, D., Smith, E. G., Vorn, R., Wagner, C., Lai, C., Gill, J., & Hinson, H. E. (2022) · Neurotrauma Reports · doi:10.1089/neur.2022.0058 · Cited by 15
The assessment of vascular function during dietary intervention trials in human subjects
McCall, D. O., McKinley, M. C., Noad, R., McKeown, P. P., McCance, D. R., Young, I. S., & Woodside, J. V. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511002996 · Cited by 14
Metadata
- Authors
- Mallat, Z., Hugel, B., Ohan, J., Lesèche, G., Freyssinet, J.-M., & Tedgui, A.
- Venue
- Circulation
- Published
- 1999-01-26
- Volume
- 99
- Issue
- 3
- Pages
- 348-353
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2163431279
- Cited by
- 638
- References
- 37
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.